Cargando…

Liver Disease Burden of Hepatitis C Virus Infection in Iran and the Potential Impact of Various Treatment Strategies on the Disease Burden

BACKGROUND: Chronic hepatitis C virus (HCV) infection is emerging as the leading cause of viral hepatitis-related liver disease in Iran. OBJECTIVES: This study estimated the current and future disease burden of HCV infection in Iran and assessed the impact of various strategies in access to HCV trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajarizadeh, Behzad, Razavi-Shearer, Devin, Merat, Shahin, Alavian, Seyed Moayed, Malekzadeh, Reza, Razavi, Homie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018306/ https://www.ncbi.nlm.nih.gov/pubmed/27642346 http://dx.doi.org/10.5812/hepatmon.37234

Ejemplares similares

The impact of immigration on hepatitis B burden in the United States: a modelling study
por: Razavi-Shearer, Devin, et al.
Publicado: (2023)

Eradication of hepatitis C virus infection in thalassemia patients in Iran using various treatment strategies
por: Moghimbeygi, Meisam, et al.
Publicado: (2020)

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
por: Keshavarz, Khosro, et al.
Publicado: (2015)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
por: Tasavon Gholamhoseini, Mohammad, et al.
Publicado: (2022)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
por: Müllhaupt, Beat, et al.
Publicado: (2015)

Disease burden of chronic hepatitis C in Brazil
por: Ferreira, Paulo Roberto Abrão, et al.
Publicado: (2015)

Modelling hepatitis B virus infection and impact of timely birth dose vaccine: A comparison of two simulation models
por: de Villiers, Margaret J., et al.
Publicado: (2020)

On the Occasion of the World Hepatitis Day: World Hepatitis Day and Our Achievements and Responsibilities in Iran
por: Alavian, Seyed Moayed
Publicado: (2012)

The Economic Burden of Liver Cirrhosis in Iran: a Cost of Illness Study
por: AKBARI SARI, Ali, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Lower Intrafamilial Transmission Rate of Hepatitis B in Patients With Hepatitis D Coinfection: A Data-Mining Approach
por: Pournik, Omid, et al.
Publicado: (2013)

Burden of Gastrointestinal and Liver Diseases in Iran: Estimates Based on the Global Burden of Disease, Injuries, and Risk Factors Study, 2010
por: Malekzadeh, Fatemeh, et al.
Publicado: (2015)

Iran's burden of disease and burden of data collection
por: Hashemian, Seyed Mohammadreza, et al.
Publicado: (2022)

Hepatitis C disease burden and strategies for elimination by 2030 in Brazil. A mathematical modeling approach
por: Benzaken, Adele Schwartz, et al.
Publicado: (2019)

HCV disease burden and population segments in Switzerland
por: Bihl, Florian, et al.
Publicado: (2021)

Appropriate Genotyping of Hepatitis B Virus in Iran
por: Jazayeri, Seyed Mohammad, et al.
Publicado: (2015)

Trend of Gastrointestinal and Liver Diseases in Iran: Results of the Global Burden of Disease Study, 2010
por: Sepanlou, Sadaf Ghajarieh, et al.
Publicado: (2015)

Epidemiology, Disease Burden, and Treatment Strategies of Chronic Hepatitis C Virus Infections in Saudi Arabia in the New Treatment Paradigm Shift
por: Aljumah, Abdulrahman A., et al.
Publicado: (2016)

Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
por: Hariri, Sanam, et al.
Publicado: (2020)

Intravenous Drug Use and Hepatitis C Virus in Iran
por: Zobeiri, Mehdi, et al.
Publicado: (2012)

Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Modelling NAFLD disease burden in four Asian regions—2019‐2030
por: Estes, Chris, et al.
Publicado: (2020)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Distribution of Hepatitis C Virus Genotypes Among Azerbaijani Patients in Capital City of Iran-Tehran
por: Bokharaei-Salim, Farah, et al.
Publicado: (2013)

Necessity for Hepatitis B Surface Antigen Screening in Pregnant Females in Iran
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver disease
por: Alavian, Seyed M, et al.
Publicado: (2004)

The Economic Burden of Acute Myeloid Leukemia in Iran
por: Alipour, Vahid, et al.
Publicado: (2022)

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
por: Biondi, Mia J., et al.
Publicado: (2023)

Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020
por: Dunn, Rick, et al.
Publicado: (2020)

Detection of Hepatitis C Virus RNA in Blood and Saliva of Transfusion-Dependent Thalassemia Patients Diagnosed with Hepatitis C
por: Hooshmand, Behzad, et al.
Publicado: (2018)

Do policymakers have any plans to reduce the economic burden of cerebral palsy in Iran?
por: Karami Matin, Behzad, et al.
Publicado: (2019)

Economic Burden of Epidermolysis Bullosa Disease in Iran
por: Forghani, Siamak Farokh, et al.
Publicado: (2021)

Distribution of Hepatitis C Virus Genotypes Among Patients With Hepatitis C Virus Infection in Hormozgan, Iran
por: Mousavi, Seyedeh Farzaneh, et al.
Publicado: (2013)

Physicians’ Knowledge and Attitude Towards Fecal Microbiota Transplant in Iran
por: Moossavi, Shirin, et al.
Publicado: (2015)

Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies
por: Rezaee Zavareh, Mohammad Saeid, et al.
Publicado: (2015)

Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis
por: Rajabi, Abdolhalim, et al.
Publicado: (2021)

Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications
por: Kwon, Jisoo A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6k7noonkupmkhk1kh9n66e4aui